IgA Nephropathy Clinical Trials in Guangzhou, Guangdong
6 recruitingGuangzhou, Guangdong, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd84 enrolled2 locationsNCT07354932
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
IgA NephropathyGlomerular Diseases
Sun Yat-sen University2,000 enrolled1 locationNCT02954419
Recruiting
Correlation of Microbiome and Metabonomics With IgA Nephropathy
IgA Nephropathy
Guangdong Provincial People's Hospital600 enrolled5 locationsNCT05190848
Recruiting
TESTING -ON Post-Trial ObservatioNal Cohort Study
Kidney DiseasesIgA NephropathyGlomerulonephritis+1 more
The George Institute366 enrolled58 locationsNCT05434325
Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
IgA Nephropathy
Sun Yat-sen University10,000 enrolled1 locationNCT03001947